poisar

Stocks · News reference

Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M Est

Aug 11, 2026, 11:59 AMBenzinga Newsdesk

Neuronetics (NASDAQ:STIM) narrows FY2026 sales outlook from $160.000 million-$166.000 million to $160.000 million-$164.000 million vs $161.125 million estimate.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

STIM
Source
benzinga
Observed
Aug 11, 2026, 11:59 AM
Checked
Aug 11, 2026, 11:59 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 17, 2026, 8:10 PMSEC EDGAR

    8-K filing — Neuronetics, Inc. (STIM)

    Filed: 2026-08-17 AccNo: 0001193125-26-354051 Size: 137 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    STIM